Zhitong Finance App News, Lisheng Pharmaceutical (002393.SZ) issued an announcement. Recently, the company received the Apomistate API (hereinafter referred to as the “API”) and the “Chemical Ingredient Marketing Application Approval Notice” (Notice Number: 2024YS00982) issued by the State Drug Administration. The API passed the marketing application for domestically produced chemical raw materials.

Zhitongcaijing · 10/17 07:57
Zhitong Finance App News, Lisheng Pharmaceutical (002393.SZ) issued an announcement. Recently, the company received the Apomistate API (hereinafter referred to as the “API”) and the “Chemical Ingredient Marketing Application Approval Notice” (Notice Number: 2024YS00982) issued by the State Drug Administration. The API passed the marketing application for domestically produced chemical raw materials.